Defilade Capital Management, L.P.

Q2 2026 13F-HR Holdings

Location
Emeryville, CA
Holdings as of
6/30/2026
Date filed
8/14/2026
Form type
13F-HR
Num holdings
39
Total value ($000)
$746,947
Net value change ($000)
+34,771 (4.9%)
New positions
20
Sold out positions
12
Turnover %
88.5%
Sector allocation + QoQ delta (equities-only)
Prev filing: 6/12/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
VEEV 42,009 NEW
BMRN 39,024 NEW
BAX 31,114 NEW
LLY 27,845 146.3%
PODD 26,938 NEW
TMO 26,038 NEW
ABT 25,931 NEW
Ascendis Pharma AS 25,297 NEW
SOLV 24,414 NEW
MDT 23,727 NEW
Top Reduces (Value $000, Stocks/ETFs)
HSIC -45,992 -100.0%
BDX -43,900 -100.0%
DXCM -33,834 -100.0%
ISRG -31,200 -100.0%
NBIX -27,656 -100.0%
ZBH -25,041 -47.8%
GMED -19,498 -63.9%
ITGR -18,746 -100.0%
BIIB -17,653 -100.0%
ICUI -17,346 -52.8%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type